{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T17:15:22Z","timestamp":1780593322555,"version":"3.54.1"},"reference-count":70,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s40620-018-0516-0","type":"journal-article","created":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T07:31:53Z","timestamp":1533108713000},"page":"27-37","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Microbiota issue in CKD: how promising are gut-targeted approaches?"],"prefix":"10.1093","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7941-8420","authenticated-orcid":false,"given":"Carmela","family":"Cosola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Rocchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Sabatino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Fiaccadori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biagio Raffaele","family":"Di Iorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loreto","family":"Gesualdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,8,1]]},"reference":[{"issue":"114","key":"516_CR1","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1038\/ki.2009.402","volume":"Suppl.","author":"P Evenepoel","year":"2009","unstructured":"Evenepoel P, Meijers BK, Bammens BR, Verbeke K (2009) Uremic toxins originating from colonic microbial metabolism. Kidney Int Suppl.(114):S12\u2013S129. https:\/\/doi.org\/10.1038\/ki.2009.402","journal-title":"Kidney Int"},{"issue":"2","key":"516_CR2","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/ki.2012.345","volume":"83","author":"ND Vaziri","year":"2013","unstructured":"Vaziri ND, Wong J, Pahl M, Piceno YM, Yuan J, DeSantis TZ, Ni Z, Nguyen TH, Andersen GL (2013) Chronic kidney disease alters intestinal microbial flora. Kidney Int 83(2):308\u2013315. https:\/\/doi.org\/10.1038\/ki.2012.345","journal-title":"Kidney Int"},{"issue":"3","key":"516_CR3","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000360010","volume":"39","author":"J Wong","year":"2014","unstructured":"Wong J, Piceno YM, DeSantis TZ, Pahl M, Andersen GL, Vaziri ND (2014) Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD. Am J Nephrol 39(3):230\u2013237. https:\/\/doi.org\/10.1159\/000360010","journal-title":"Am J Nephrol"},{"issue":"2\u20133","key":"516_CR4","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1159\/000355785","volume":"39","author":"E Montemurno","year":"2014","unstructured":"Montemurno E, Cosola C, Dalfino G, Daidone G, De Angelis M, Gobbetti M, Gesualdo L (2014) What would you like to eat, Mr CKD microbiota? A Mediterranean diet. Kidney Blood Press Res 39(2\u20133):114\u2013123. https:\/\/doi.org\/10.1159\/000355785","journal-title":"Kidney Blood Press Res"},{"issue":"3","key":"516_CR5","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1681\/ASN.2013060597","volume":"25","author":"TL Sirich","year":"2014","unstructured":"Sirich TL, Funk BA, Plummer NS, Hostetter TH, Meyer TW (2014) Prominent accumulation in hemodialysis patients of solutes normally cleared by tubular secretion. J Am Soc Nephrol 25(3):615\u2013622. https:\/\/doi.org\/10.1681\/ASN.2013060597","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"516_CR6","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1007\/s00216-012-5929-3","volume":"403","author":"Y Itoh","year":"2012","unstructured":"Itoh Y, Ezawa A, Kikuchi K, Tsuruta Y, Niwa T (2012) Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography\/tandem mass spectrometry and their effects on endothelial ROS production. Anal Bioanal Chem 403(7):1841\u20131850. https:\/\/doi.org\/10.1007\/s00216-012-5929-3","journal-title":"Anal Bioanal Chem"},{"issue":"9","key":"516_CR7","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1681\/ASN.2013101062","volume":"25","author":"R Vanholder","year":"2014","unstructured":"Vanholder R, Schepers E, Pletinck A, Nagler EV, Glorieux G (2014) The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review. J Am Soc Nephrol 25(9):1897\u20131907. https:\/\/doi.org\/10.1681\/ASN.2013101062","journal-title":"J Am Soc Nephrol"},{"key":"516_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2018.03.003","author":"C Cosola","year":"2018","unstructured":"Cosola C, Rocchetti MT, Cupisti A, Gesualdo L (2018) Microbiota metabolites: pivotal players of cardiovascular damage in chronic kidney disease. Pharmacol Res. https:\/\/doi.org\/10.1016\/j.phrs.2018.03.003","journal-title":"Pharmacol Res"},{"issue":"3","key":"516_CR9","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/CIRCRESAHA.116.305360","volume":"116","author":"WH Tang","year":"2015","unstructured":"Tang WH, Wang Z, Kennedy DJ, Wu Y, Buffa JA, Agatisa-Boyle B, Li XS, Levison BS, Hazen SL (2015) Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ Res 116(3):448\u2013455. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.305360","journal-title":"Circ Res"},{"issue":"12","key":"516_CR10","doi-asserted-by":"publisher","first-page":"e0143731","DOI":"10.1371\/journal.pone.0143731","volume":"10","author":"X Hai","year":"2015","unstructured":"Hai X, Landeras V, Dobre MA, DeOreo P, Meyer TW, Hostetter TH (2015) Mechanism of prominent trimethylamine oxide (TMAO) accumulation in hemodialysis patients. PLoS One 10(12):e0143731. https:\/\/doi.org\/10.1371\/journal.pone.0143731","journal-title":"PLoS One"},{"key":"516_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfx203","author":"BR Iorio Di","year":"2017","unstructured":"Di Iorio BR, Marzocco S, Bellasi A, De Simone E, Dal Piaz F, Rocchetti MT, Cosola C, Di Micco L, Gesualdo L (2017) Nutritional therapy reduces protein carbamylation through urea lowering in chronic kidney disease. Nephrol Dial Transplant. https:\/\/doi.org\/10.1093\/ndt\/gfx203","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"516_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000345969","volume":"37","author":"ND Vaziri","year":"2013","unstructured":"Vaziri ND, Yuan J, Norris K (2013) Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease. Am J Nephrol 37(1):1\u20136. https:\/\/doi.org\/10.1159\/000345969","journal-title":"Am J Nephrol"},{"issue":"1","key":"516_CR13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1172\/JCI37672","volume":"120","author":"M D\u2019Apolito","year":"2010","unstructured":"D\u2019Apolito M, Du X, Zong H, Catucci A, Maiuri L, Trivisano T, Pettoello-Mantovani M, Campanozzi A, Raia V, Pessin JE, Brownlee M, Giardino I (2010) Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure. J Clin Investig 120(1):203\u2013213. https:\/\/doi.org\/10.1172\/JCI37672","journal-title":"J Clin Investig"},{"issue":"5","key":"516_CR14","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/ki.2014.218","volume":"86","author":"D El-Gamal","year":"2014","unstructured":"El-Gamal D, Rao SP, Holzer M, Hallstr\u00f6m S, Haybaeck J, Gauster M, Wadsack C, Kozina A, Frank S, Schicho R, Schuligoi R, Heinemann A, Marsche G (2014) The urea decomposition product cyanate promotes endothelial dysfunction. Kidney Int 86(5):923\u2013931. https:\/\/doi.org\/10.1038\/ki.2014.218","journal-title":"Kidney Int"},{"key":"516_CR15","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1159\/000189334","volume":"74","author":"M Hida","year":"1996","unstructured":"Hida M, Aiba Y, Sawamura S, Suzuki N, Satoh T, Koga Y (1996) Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of Lebenin, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis. Nephron 74:349\u2013355. https:\/\/doi.org\/10.1159\/000189334","journal-title":"Nephron"},{"issue":"10","key":"516_CR16","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1007\/s10482-016-0737-y","volume":"109","author":"S Jiang","year":"2016","unstructured":"Jiang S, Xie S, Lv D, Zhang Y, Deng J, Zeng L, Chen Y (2016) A reduction in the butyrate producing species Roseburia spp. and Faecalibacterium prausnitzii is associated with chronic kidney disease progression. Antonie Van Leeuwenhoek 109(10):1389\u20131396. https:\/\/doi.org\/10.1007\/s10482-016-0737-y","journal-title":"Antonie Van Leeuwenhoek"},{"issue":"1","key":"516_CR17","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/s41598-017-01387-y","volume":"7","author":"KY Xu","year":"2017","unstructured":"Xu KY, Xia GH, Lu JQ, Chen MX, Zhen X, Wang S, You C, Nie J, Zhou HW, Yin J (2017) Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients. Sci Rep 7(1):1445. https:\/\/doi.org\/10.1038\/s41598-017-01387-y","journal-title":"Sci Rep"},{"issue":"6","key":"516_CR18","doi-asserted-by":"publisher","first-page":"e99006","DOI":"10.1371\/journal.pone.0099006","volume":"9","author":"M Angelis De","year":"2014","unstructured":"De Angelis M, Montemurno E, Piccolo M, Vannini L, Lauriero G, Maranzano V, Gozzi G, Serrazanetti D, Dalfino G, Gobbetti M, Gesualdo L (2014) Microbiota and metabolome associated with immunoglobulin A nephropathy (IgAN). PLoS One 9(6):e99006. https:\/\/doi.org\/10.1371\/journal.pone.0099006","journal-title":"PLoS One"},{"issue":"2","key":"516_CR19","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00248-015-0592-9","volume":"70","author":"M Piccolo","year":"2015","unstructured":"Piccolo M, De Angelis M, Lauriero G, Montemurno E, Di Cagno R, Gesualdo L, Gobbetti M (2015) Salivary microbiota associated with immunoglobulin A nephropathy. Microb Ecol 70(2):557\u2013565. https:\/\/doi.org\/10.1007\/s00248-015-0592-9","journal-title":"Microb Ecol"},{"issue":"3","key":"516_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11892-017-0841-z","volume":"17","author":"A Sabatino","year":"2017","unstructured":"Sabatino A, Regolisti G, Cosola C, Gesualdo L, Fiaccadori E (2017) Intestinal microbiota in type 2 diabetes and chronic kidney disease. Curr Diabetes Rep 17(3):16. https:\/\/doi.org\/10.1007\/s11892-017-0841-z","journal-title":"Curr Diabetes Rep"},{"issue":"8","key":"516_CR21","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/j.1440-1797.2012.01647.x","volume":"17","author":"F Wang","year":"2012","unstructured":"Wang F, Jiang H, Shi K, Ren Y, Zhang P, Cheng S (2012) Gut bacterial translocation is associated with microinflammation in end-stage renal disease patients. Nephrology (Carlton) 17(8):733\u2013738. https:\/\/doi.org\/10.1111\/j.1440-1797.2012.01647.x","journal-title":"Nephrology (Carlton)"},{"issue":"1","key":"516_CR22","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1681\/ASN.2015111285","volume":"28","author":"K Andersen","year":"2017","unstructured":"Andersen K, Kesper MS, Marschner JA, Konrad L, Ryu M, Kumar Vr S, Kulkarni OP, Mulay SR, Romoli S, Demleitner J, Schiller P, Dietrich A, M\u00fcller S, Gross O, Ruscheweyh HJ, Huson DH, Stecher B, Anders HJ (2017) Intestinal dysbiosis, barrier dysfunction, and bacterial translocation account for CKD-related systemic inflammation. J Am Soc Nephrol 28(1):76\u201383. https:\/\/doi.org\/10.1681\/ASN.2015111285","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"516_CR23","first-page":"1077","volume":"19","author":"D Viggiano","year":"2015","unstructured":"Viggiano D, Ianiro G, Vanella G, Bibb\u00f2 S, Bruno G, Simeone G, Mele G (2015) Gut barrier in health and disease: focus on childhood. Eur Rev Med Pharmacol Sci 19(6):1077\u20131085","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"8","key":"516_CR24","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1681\/ASN.2014060530","volume":"26","author":"E Mishima","year":"2015","unstructured":"Mishima E, Fukuda S, Shima H, Hirayama A, Akiyama Y, Takeuchi Y, Fukuda NN, Suzuki T, Suzuki C, Yuri A, Kikuchi K, Tomioka Y, Ito S, Soga T, Abe T (2015) Alteration of the intestinal environment by lubiprostone is associated with amelioration of adenine-induced CKD. J Am Soc Nephrol 26(8):1787\u20131794. https:\/\/doi.org\/10.1681\/ASN.2014060530","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"516_CR25","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/ndt\/gfv353","volume":"31","author":"A Yoshifuji","year":"2016","unstructured":"Yoshifuji A, Wakino S, Irie J, Tajima T, Hasegawa K, Kanda T, Tokuyama H, Hayashi K, Itoh H (2016) Gut Lactobacillus protects against the progression of renal damage by modulating the gut environment in rats. Nephrol Dial Transplant 31(3):401\u2013412. https:\/\/doi.org\/10.1093\/ndt\/gfv353","journal-title":"Nephrol Dial Transplant"},{"issue":"14","key":"516_CR26","doi-asserted-by":"publisher","first-page":"17468","DOI":"10.18632\/oncotarget.8160","volume":"7","author":"YQ Zeng","year":"2016","unstructured":"Zeng YQ, Dai Z, Lu F, Lu Z, Liu X, Chen C, Qu P, Li D, Hua Z, Qu Y, Zou C (2016) Emodin via colonic irrigation modulates gut microbiota and reduces uremic toxins in rats with chronic kidney disease. Oncotarget 7(14):17468\u201317478. https:\/\/doi.org\/10.18632\/oncotarget.8160","journal-title":"Oncotarget"},{"issue":"6","key":"516_CR27","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1002\/hep.29306","volume":"66","author":"JS Bajaj","year":"2017","unstructured":"Bajaj JS, Kassam Z, Fagan A, Gavis EA, Liu E, Cox IJ, Kheradman R, Heuman D, Wang J, Gurry T, Williams R, Sikaroodi M, Fuchs M, Alm E, John B, Thacker LR, Riva A, Smith M, Taylor-Robinson SD, Gillevet PM (2017) Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: a randomized clinical trial. Hepatology 66(6):1727\u20131738. https:\/\/doi.org\/10.1002\/hep.29306","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"516_CR28","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1681\/ASN.V13suppl_1s28","volume":"13","author":"AR Qureshi","year":"2002","unstructured":"Qureshi AR, Alvestrand A, Divino-Filho JC, Gutierrez A, Heimb\u00fcrger O, Lindholm B, Bergstr\u00f6m J (2002) Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol 13(Suppl 1):S28\u2013S36","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"516_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0132589","volume":"10","author":"CJ Lin","year":"2015","unstructured":"Lin CJ, Wu V, Wu PC, Wu CJ (2015) Meta-analysis of the associations of p-cresyl sulfate (PCS) and indoxyl sulfate (IS) with cardiovascular events and all-cause mortality in patients with chronic renal failure. PLoS One 10(7):1\u201314. https:\/\/doi.org\/10.1371\/journal.pone.0132589","journal-title":"PLoS One"},{"issue":"6","key":"516_CR30","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1093\/ndt\/gfm861","volume":"23","author":"A Adijiang","year":"2008","unstructured":"Adijiang A, Goto S, Uramoto S, Nishijima F, Niwa T (2008) Indoxyl sulphate promotes aortic calcification with expression of osteoblast-specific proteins in hypertensive rats. Nephrol Dial Transplant 23(6):1892\u20131901. https:\/\/doi.org\/10.1093\/ndt\/gfm861","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"516_CR31","doi-asserted-by":"publisher","first-page":"C1110","DOI":"10.1152\/ajpcell.00217.2010","volume":"299","author":"H Shimizu","year":"2010","unstructured":"Shimizu H, Bolati D, Adijiang A, Enomoto A, Nishijima F, Dateki M, Niwa T (2010) Senescence and dysfunction of proximal tubular cells are associated with activated p53 expression by indoxyl sulfate. Am J Physiol 299(5):C1110\u2013C1117. https:\/\/doi.org\/10.1152\/ajpcell.00217.2010","journal-title":"Am J Physiol"},{"issue":"3","key":"516_CR32","doi-asserted-by":"publisher","first-page":"e34026","DOI":"10.1371\/journal.pone.0034026","volume":"7","author":"CY Sun","year":"2012","unstructured":"Sun CY, Chang SC, Wu MS (2012) Uremic toxins induce kidney fibrosis by activating intrarenal renin\u2013angiotensin\u2013aldosterone system associated epithelial-to-mesenchymal transition. PLoS One 7(3):e34026. https:\/\/doi.org\/10.1371\/journal.pone.0034026","journal-title":"PLoS One"},{"issue":"6","key":"516_CR33","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.kint.2017.05.012","volume":"92","author":"T Shafi","year":"2017","unstructured":"Shafi T, Sirich TL, Meyer TW, Hostetter TH, Plummer NS, Hwang S, Melamed ML, Banerjee T, Coresh J, Powe NR (2017) Results of the HEMO study suggest that p-cresol sulfate and indoxyl sulfate are not associated with cardiovascular outcomes. Kidney Int 92(6):1484\u20131492. https:\/\/doi.org\/10.1016\/j.kint.2017.05.012","journal-title":"Kidney Int"},{"key":"516_CR34","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.004947","author":"Y Heianza","year":"2017","unstructured":"Heianza Y, Ma W, Manson JE, Rexrode KM, Qi L (2017) Gut microbiota metabolites and risk of major adverse cardiovascular disease events and death: a systematic review and meta-analysis of prospective studies. J Am Heart Assoc. https:\/\/doi.org\/10.1161\/JAHA.116.004947","journal-title":"J Am Heart Assoc"},{"key":"516_CR35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.bbi.2017.01.016","volume":"66","author":"R Rieder","year":"2017","unstructured":"Rieder R, Wisniewski PJ, Alderman BL, Campbell SC (2017) Microbes and mental health: a review. Brain Behav Immun 66:9\u201317. https:\/\/doi.org\/10.1016\/j.bbi.2017.01.016","journal-title":"Brain Behav Immun"},{"issue":"1","key":"516_CR36","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1046\/j.1523-1755.2002.00411.x","volume":"62","author":"AA Lopes","year":"2002","unstructured":"Lopes AA, Bragg J, Young E, Goodkin D, Mapes D, Combe C, Piera L, Held P, Gillespie B, Port FK, Dialysis Outcomes and Practice Patterns Study (DOPPS) (2002) Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int 62(1):199\u2013207. https:\/\/doi.org\/10.1046\/j.1523-1755.2002.00411.x","journal-title":"Kidney Int"},{"issue":"4","key":"516_CR37","doi-asserted-by":"publisher","first-page":"c256","DOI":"10.1159\/000124749","volume":"108","author":"J Chilcot","year":"2008","unstructured":"Chilcot J, Wellsted D, Da Silva-Gane M, Farrington K (2008) Depression on dialysis. Nephron Clin Pract 108(4):c256\u201364. https:\/\/doi.org\/10.1159\/000124749","journal-title":"Nephron Clin Pract"},{"issue":"1","key":"516_CR38","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/hdi.12200","volume":"19","author":"M Taraz","year":"2015","unstructured":"Taraz M, Taraz S, Dashti-Khavidaki S (2015) Association between depression and inflammatory\/anti-inflammatory cytokines in chronic kidney disease and end-stage renal disease patients: a review of literature. Hemodial Int 19(1):11\u201322. https:\/\/doi.org\/10.1111\/hdi.12200","journal-title":"Hemodial Int"},{"issue":"1","key":"516_CR39","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12882-016-0387-3","volume":"17","author":"N Karu","year":"2016","unstructured":"Karu N, Mckercher C, Nichols DS, Davies N, Shellie RA, Hilder EF, Jose MD (2016) Tryptophan metabolism, its relation to inflammation and stress markers and association with psychological and cognitive functioning: Tasmanian chronic kidney disease pilot study. BMC Nephrol 17(1):171. https:\/\/doi.org\/10.1186\/s12882-016-0387-3","journal-title":"BMC Nephrol"},{"issue":"Pt B","key":"516_CR40","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.neuropharm.2016.08.003","volume":"112","author":"R Schwarcz","year":"2017","unstructured":"Schwarcz R, Stone TW (2017) The kynurenine pathway and the brain: challenges, controversies and promises. Neuropharmacology 112(Pt B):237\u2013247. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.08.003","journal-title":"Neuropharmacology"},{"issue":"1","key":"516_CR41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.genhosppsych.2012.08.009","volume":"35","author":"HJ Hsu","year":"2013","unstructured":"Hsu HJ, Yen CH, Chen CK, Wu IW, Lee CC, Sun CY, Chang SJ, Chou CC, Hsieh MF, Chen CY, Hsu CY, Tsai CJ, Wu MS (2013) Association between uremic toxins and depression in patients with chronic kidney disease undergoing maintenance hemodialysis. Gen Hosp Psychiatry 35(1):23\u201327. https:\/\/doi.org\/10.1016\/j.genhosppsych.2012.08.009","journal-title":"Gen Hosp Psychiatry"},{"key":"516_CR42","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.neuro.2016.01.006","volume":"53","author":"YC Yeh","year":"2016","unstructured":"Yeh YC, Huang MF, Liang SS, Hwang SJ, Tsai JC, Liu TL, Wu PH, Yang YH, Kuo KC, Kuo MC, Chen CS (2016) Indoxyl sulfate, not p-cresyl sulfate, is associated with cognitive impairment in early-stage chronic kidney disease. Neurotoxicology 53:148\u2013152. https:\/\/doi.org\/10.1016\/j.neuro.2016.01.006","journal-title":"Neurotoxicology"},{"issue":"1","key":"516_CR43","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1046\/j.1471-4159.2002.01108.x","volume":"83","author":"S Ohtsuki","year":"2002","unstructured":"Ohtsuki S, Asaba H, Takanaga H, Deguchi T, Hosoya K, Otagiri M, Terasaki T (2002) Role of blood-brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain. J Neurochem 83(1):57\u201366","journal-title":"J Neurochem"},{"issue":"4","key":"516_CR44","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1007\/s11095-006-9183-2","volume":"24","author":"K Iwata","year":"2007","unstructured":"Iwata K, Watanabe H, Morisaki T, Matsuzaki T, Ohmura T, Hamada A, Saito H (2007) Involvement of indoxyl sulfate in renal and central nervous system toxicities during cisplatin-induced acute renal failure. Pharm Res 24(4):662\u2013671. https:\/\/doi.org\/10.1007\/s11095-006-9183-2","journal-title":"Pharm Res"},{"key":"516_CR45","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.neuroscience.2015.07.055","volume":"304","author":"N Oshima","year":"2015","unstructured":"Oshima N, Onimaru H, Matsubara H, Uchida T, Watanabe A, Takechi H, Nishida Y, Kumagai H (2015) Uric acid, indoxyl sulfate, and methylguanidine activate bulbospinal neurons in the RVLM via their specific transporters and by producing oxidative stress. Neuroscience 304:133\u2013145. https:\/\/doi.org\/10.1016\/j.neuroscience.2015.07.055","journal-title":"Neuroscience"},{"key":"516_CR46","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/306189","author":"M Mogi","year":"2011","unstructured":"Mogi M, Horiuchi M (2011) Clinical interaction between brain and kidney in small vessel disease. Cardiol Res Pract. https:\/\/doi.org\/10.4061\/2011\/306189","journal-title":"Cardiol Res Pract"},{"issue":"1","key":"516_CR47","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12882-016-0275-x","volume":"17","author":"GB Piccoli","year":"2016","unstructured":"Piccoli GB, Capizzi I, Vigotti FN, Leone F, D\u2019Alessandro C, Giuffrida D, Nazha M, Roggero S, Colombi N, Mauro G, Castelluccia N, Cupisti A, Avagnina P (2016) Low protein diets in patients with chronic kidney disease: a bridge between mainstream and complementary-alternative medicines? BMC Nephrol 17(1):76. https:\/\/doi.org\/10.1186\/s12882-016-0275-x","journal-title":"BMC Nephrol"},{"issue":"11","key":"516_CR48","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1056\/NEJM198209093071104","volume":"307","author":"BM Brenner","year":"1982","unstructured":"Brenner BM, Meyer TW, Hostetter TH (1982) Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 307(11):652\u2013659. https:\/\/doi.org\/10.1056\/NEJM198209093071104","journal-title":"N Engl J Med"},{"issue":"5","key":"516_CR49","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1046\/j.1523-1755.2003.00282.x","volume":"64","author":"BR Iorio Di","year":"2003","unstructured":"Di Iorio BR, Minutolo R, De Nicola L, Bellizzi V, Catapano F, Iodice C, Rubino R, Conte G (2003) Supplemented very low protein diet ameliorates responsiveness to erythropoietin in chronic renal failure. Kidney Int 64(5):1822\u20131828. https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00282.x","journal-title":"Kidney Int"},{"issue":"3","key":"516_CR50","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/sj.ki.5001955","volume":"71","author":"V Bellizzi","year":"2007","unstructured":"Bellizzi V, Di Iorio BR, De Nicola L, Minutolo R, Zamboli P, Trucillo P, Catapano F, Cristofano C, Scalfi L, Conte G, ERIKA Study-Group (2007) Very low protein diet supplemented with ketoanalogs improves blood pressure control in chronic kidney disease. Kidney Int 71(3):245\u2013251. https:\/\/doi.org\/10.1038\/sj.ki.5001955","journal-title":"Kidney Int"},{"issue":"2","key":"516_CR51","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1093\/ndt\/gfm576","volume":"23","author":"B Cianciaruso","year":"2008","unstructured":"Cianciaruso B, Pota A, Pisani A, Torraca S, Annecchini R, Lombardi P, Capuano A, Nazzaro P, Bellizzi V, Sabbatini M (2008) Metabolic effects of two low protein diets in chronic kidney disease stage 4\u20135 a randomized controlled trial. Nephrol Dial Transplant 23(2):636\u2013644. https:\/\/doi.org\/10.1093\/ndt\/gfm576","journal-title":"Nephrol Dial Transplant"},{"key":"516_CR52","doi-asserted-by":"publisher","first-page":"CD001892","DOI":"10.1002\/14651858.CD001892.pub3","volume":"3","author":"D Fouque","year":"2009","unstructured":"Fouque D, Laville M (2009) Low protein diets for chronic kidney disease in non diabetic adults. Cochrane Database Syst Rev 3:CD001892. https:\/\/doi.org\/10.1002\/14651858.CD001892.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"516_CR53","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1053\/j.ajkd.2007.02.278","volume":"49","author":"G Brunori","year":"2007","unstructured":"Brunori G, Viola BF, Parrinello G, De Biase V, Como G, Franco V, Garibotto G, Zubani R, Cancarini GC (2007) Efficacy and safety of a very-low-protein diet when postponing dialysis in the elderly: a prospective randomized multicenter controlled study. Am J Kidney Dis 49(5):569\u2013580. https:\/\/doi.org\/10.1053\/j.ajkd.2007.02.278","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"516_CR54","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1007\/s12325-010-0059-9","volume":"27","author":"N Ranganathan","year":"2010","unstructured":"Ranganathan N, Ranganathan P, Friedman EA, Joseph A, Delano B, Goldfarb DS, Tam P, Rao AV, Anteyi E, Musso CG (2010) Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease. Adv Ther 27(9):634\u2013647. https:\/\/doi.org\/10.1007\/s12325-010-0059-9","journal-title":"Adv Ther"},{"issue":"4","key":"516_CR55","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.3390\/nu5041417","volume":"5","author":"J Slavin","year":"2013","unstructured":"Slavin J (2013) Fiber and prebiotics: mechanisms and health benefits. Nutrients 5(4):1417\u20131435. https:\/\/doi.org\/10.3390\/nu5041417","journal-title":"Nutrients"},{"key":"516_CR56","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1093\/ajcn\/63.3.392","volume":"63","author":"DZ Bliss","year":"1996","unstructured":"Bliss DZ, Stein TP, Schleifer CR, Settle RG (1996) Supplementation with gum arabic fiber increases fecal nitrogen excretion and lowers serum urea nitrogen concentration in chronic renal failure patients consuming a low-protein diet. Am J Clin Nutr 63:392\u2013398","journal-title":"Am J Clin Nutr"},{"key":"516_CR57","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1093\/ndt\/gfp414","volume":"25","author":"BKI Meijers","year":"2010","unstructured":"Meijers BKI, De Preter V, Verbeke K, Vanrenterghem Y, Evenepoel P (2010) p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin. Nephrol Dial Transplant 25:219\u2013224. https:\/\/doi.org\/10.1093\/ndt\/gfp414","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"516_CR58","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.numecd.2015.03.015","volume":"25","author":"M Rossi","year":"2015","unstructured":"Rossi M, Johnson DW, Xu H, Carrero JJ, Pascoe E, French C, Campbell KL (2015) Dietary protein-fiber ratio associates with circulating levels of indoxyl sulfate and p-cresyl sulfate in chronic kidney disease patients. Nutr Metab Cardiovasc Dis 25(9):860\u2013865. https:\/\/doi.org\/10.1016\/j.numecd.2015.03.015","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"516_CR59","doi-asserted-by":"publisher","first-page":"e0169635","DOI":"10.1371\/journal.pone.0169635","volume":"12","author":"C Cosola","year":"2017","unstructured":"Cosola C, De Angelis M, Rocchetti MT, Montemurno E, Maranzano V, Dalfino G, Manno C, Zito A, Gesualdo M, Ciccone MM, Gobbetti M, Gesualdo L (2017) Beta-glucans supplementation associates with reduction in p-cresyl sulfate levels and improved endothelial vascular reactivity in healthy individuals. PLoS One 12(1):e0169635. https:\/\/doi.org\/10.1371\/journal.pone.0169635","journal-title":"PLoS One"},{"issue":"22","key":"516_CR60","doi-asserted-by":"publisher","first-page":"7945","DOI":"10.1128\/AEM.02507-15","volume":"81","author":"M Angelis De","year":"2015","unstructured":"De Angelis M, Montemurno E, Vannini L, Cosola C, Cavallo N, Gozzi G, Maranzano V, Di Cagno R, Gobbetti M, Gesualdo L (2015) Effect of whole-grain barley on the human fecal microbiota and metabolome. Appl Environ Microbiol 81(22):7945\u20137956. https:\/\/doi.org\/10.1128\/AEM.02507-15","journal-title":"Appl Environ Microbiol"},{"key":"516_CR61","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1053\/j.jrn.2012.04.002","volume":"23","author":"YA Salmean","year":"2013","unstructured":"Salmean YA, Segal MS, Langkamp-Henken B, Canales MT, Zello GA, Dahl WJ (2013) Foods with added fiber lower serum creatinine levels in patients with chronic kidney disease. J Ren Nutr 23:e29\u2013e32. https:\/\/doi.org\/10.1053\/j.jrn.2012.04.002","journal-title":"J Ren Nutr"},{"key":"516_CR62","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1053\/j.jrn.2004.09.028","volume":"15","author":"K Taki","year":"2005","unstructured":"Taki K, Takayama F, Niwa T (2005) Beneficial effects of Bifidobacteria in a gastroresistant seamless capsule on hyperhomocysteinemia in hemodialysis patients. J Ren Nutr 15:77\u201380","journal-title":"J Ren Nutr"},{"key":"516_CR63","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/ckj\/sfs072","volume":"5","author":"T Ogawa","year":"2012","unstructured":"Ogawa T, Shimada M, Nagano N, Ito K, Ando T, Shimomura Y, Ando Y, Otsuka K (2012) Oral administration of Bifidobacterium longum in a gastro-resistant seamless capsule decreases serum phosphate levels in patients receiving haemodialysis. Clin Kidney J 5:373\u2013374. https:\/\/doi.org\/10.1093\/ckj\/sfs072","journal-title":"Clin Kidney J"},{"issue":"4","key":"516_CR64","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3920\/BM2014.0088","volume":"6","author":"IK Wang","year":"2015","unstructured":"Wang IK, Wu YY, Yang YF, Ting IW, Lin CC, Yen TH, Chen JH, Wang CH, Huang CC, Lin HC (2015) The effect of probiotics on serum levels of cytokine and endotoxin in peritoneal dialysis patients: a randomised, double-blind, placebo-controlled trial. Benef Microbes 6(4):423\u2013430. https:\/\/doi.org\/10.3920\/BM2014.0088","journal-title":"Benef Microbes"},{"issue":"2","key":"516_CR65","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.kint.2016.09.040","volume":"91","author":"A Soleimani","year":"2017","unstructured":"Soleimani A, Zarrati Mojarrad M, Bahmani F, Taghizadeh M, Ramezani M, Tajabadi-Ebrahimi M, Jafari P, Esmaillzadeh A, Asemi Z (2017) Probiotic supplementation in diabetic hemodialysis patients has beneficial metabolic effects. Kidney Int 91(2):435\u2013442. https:\/\/doi.org\/10.1016\/j.kint.2016.09.040","journal-title":"Kidney Int"},{"key":"516_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/nu9050444","author":"A Cupisti","year":"2017","unstructured":"Cupisti A, D\u2019Alessandro C, Gesualdo L, Cosola C, Gallieni M, Egidi MF, Fusaro M (2017) Non-traditional aspects of renal diets: focus on fiber, alkali and vitamin K1 intake. Nutrients. https:\/\/doi.org\/10.3390\/nu9050444","journal-title":"Nutrients"},{"issue":"5","key":"516_CR67","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1681\/ASN.2015030279","volume":"27","author":"R Poesen","year":"2016","unstructured":"Poesen R, Windey K, Neven E, Kuypers D, De Preter V, Augustijns P, D\u2019Haese P, Evenepoel P, Verbeke K, Meijers B (2016) The influence of CKD on colonic microbial metabolism. J Am Soc Nephrol 27(5):1389\u20131399. https:\/\/doi.org\/10.1681\/ASN.2015030279","journal-title":"J Am Soc Nephrol"},{"issue":"1\u20133","key":"516_CR68","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1159\/000346628","volume":"35","author":"S Marzocco","year":"2013","unstructured":"Marzocco S, Dal Piaz F, Di Micco L, Torraca S, Sirico ML, Tartaglia D, Autore G, Di Iorio B (2013) Very low protein diet reduces indoxyl sulfate levels in chronic kidney disease. Blood Purif 35(1\u20133):196\u2013201. https:\/\/doi.org\/10.1159\/000346628","journal-title":"Blood Purif"},{"key":"516_CR69","doi-asserted-by":"publisher","DOI":"10.1053\/j.jrn.2017.11.007","author":"AP Black","year":"2018","unstructured":"Black AP, Anjos JS, Cardozo L, Carmo FL, Dolenga CJ, Nakao LS, de Carvalho Ferreira D, Rosado A, Carraro Eduardo JC, Mafra D (2018) Does low-protein diet influence the uremic toxin serum levels from the gut microbiota in nondialysis chronic kidney disease patients? J Ren Nutr. https:\/\/doi.org\/10.1053\/j.jrn.2017.11.007","journal-title":"J Ren Nutr"},{"key":"516_CR70","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-018-0497-z","author":"A Cupisti","year":"2018","unstructured":"Cupisti A, Brunori G, Di Iorio BR, D\u2019Alessandro C, Pasticci F, Cosola C, Bellizzi V, Bolasco P, Capitanini A, Fantuzzi AL, Gennari A, Piccoli GB, Quintaliani G, Salomone M, Sandrini M, Santoro D, Babini P, Fiaccadori E, Gambaro G, Garibotto G, Gregorini M, Mandreoli M, Minutolo R, Cancarini G, Conte G, Locatelli F, Gesualdo L (2018) Nutritional treatment of advanced CKD: twenty consensus statements. J Nephrol. https:\/\/doi.org\/10.1007\/s40620-018-0497-z","journal-title":"J Nephrol"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-018-0516-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-018-0516-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-018-0516-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:56:12Z","timestamp":1777564572000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/32\/1\/27\/8328177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,1]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["516"],"URL":"https:\/\/doi.org\/10.1007\/s40620-018-0516-0","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,1]]},"assertion":[{"value":"20 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"For this type of study formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}